Chronic Obstructive Pulmonary Disease
The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
What is Chronic Obstructive Pulmonary Disease?
Chronic obstructive pulmonary disease (COPD) is an assortment of lung disorders that includes...
In a new study, researchers reported severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) spike (S) protein and S messenger ribonucleic acid (mRNA) nuclear co-translocation as a novel feature of SARS-CoV-2 pathogenesis.
Researchers assessed the chances of COVID-19 hospitalization after three versus two mRNA vaccine doses.
Researchers explored the potential of a nuclear magnetic resonance spectroscopy-based metabolomic platform to estimate the risks for the onset of several medical conditions.
A recent study assessed the dynamic trajectory of COVID-19 symptom burden as well as symptom persistence in those who survived SARS-CoV-2 infection for two years after being discharged from hospitals.
In a recent study posted to the medRxiv* preprint server, researchers evaluated the prevalence, risk factors, and impact of post-coronavirus disease (COVID) conditions (PCC) or long COVID on daily activities among adults residing in the United States (US).
A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered that Neisseria - a genus of bacteria that lives in the human body - is not as harmless as previously thought, and can cause infections in patients with bronchiectasis, asthma, and chronic obstructive pulmonary disease (COPD).
In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.
A cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an unselected community population was 1.4%. The prevalence increased with age, from 0.2% in adults aged 18 to 25 up to 3.2% in adults older than 65 years of age. However, approximately 70% of identified tumors were nonfunctioning, meaning they did not make extra hormones, regardless of the participant's age. The findings are published in Annals of Internal Medicine.
A new study revealed a link between air pollution and lung cancer in non-smokers.
A team of researchers characterized individual-level illness perception, both cognitive and emotional, following COVID-19.
In a recent The Lancet study on COPD, scientists focussed on eliminating the disease by challenging accepted dogma and raising important questions.
Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people who do not have chronic obstructive pulmonary disease (COPD), but who do have respiratory symptoms and a history of smoking.
Artificial intelligence (AI) can be used to detect COVID-19 infection in people's voices by means of a mobile phone app, according to research to be presented on Monday at the European Respiratory Society International Congress in Barcelona, Spain.
The impact of breathing diesel exhaust fumes may be more severe for females than males, according to new research that will be presented at the European Respiratory Society International Congress in Barcelona, Spain.
In a new study, researchers assessed the correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) antigen levels and hospitalized patient outcomes.
In a new study, researchers assessed the association of COVID-19 and influenza with thrombotic events among patients.
Nepal has the world's highest age-adjusted death rate for chronic lung disease at 182.5 per 100,000 population, with more than 3,000 years lost to ill health or disability from the condition, according to an international study.
A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.
Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. became the second in the world to successfully implant the Impella Bridge-to-Recovery (BTR)™ heart pump for the technology's U.S. Food and Drug Administration (FDA) early feasibility study (EFS) investigational device exemption (IDE).
In a new study, researchers assessed the risk factors associated with COVID-19-related hospitalization or mortality.